Innovative Eyewear, Inc. (LUCY)
NASDAQ:LUCY
Top Page
Innovative Eyewear, Inc.
(NASDAQ:LUCY)
Select Model
Select Model
Rating:42Neutral
Price Target:
$1.00
▼(-7.41% Downside)
Action:ReiteratedDate:03/26/26
The score is held down primarily by extreme operating losses and heavy negative free cash flow, which outweigh strong revenue growth and improved gross margin. Technicals add additional pressure with the stock trading below major moving averages and a negative MACD. Valuation cannot be favorably assessed with a non-meaningful P/E and no dividend yield data.
Positive Factors
High revenue growth
Revenue has expanded sharply (over 50% reported growth), indicating strong market demand and product traction for smart eyewear. Sustained top-line expansion over several quarters supports scale opportunities in retail and wholesale channels and underpins long-term market positioning.
Negative Factors
Severe negative cash flow
Massive and accelerating operating and free cash outflows materially increase funding risk and the need for external capital. Persistent negative cash flow limits ability to execute growth initiatives, requires dilution or debt financing, and threatens sustainability if improvements in margins or capital raising fail.
Read all positive and negative factors
Positive Factors
Negative Factors
High revenue growth
Revenue has expanded sharply (over 50% reported growth), indicating strong market demand and product traction for smart eyewear. Sustained top-line expansion over several quarters supports scale opportunities in retail and wholesale channels and underpins long-term market positioning.
Read all positive factors
Innovative Eyewear, Inc. (LUCY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.80M
Dividend YieldN/A
Average Volume (3M)543.31K
Price to Earnings (P/E)―
Beta (1Y)2.18
Revenue Growth53.22%
EPS Growth72.69%
CountryUS
Employees11
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-0.14
Shares Outstanding6,300,661
10 Day Avg. Volume196,778
30 Day Avg. Volume543,314
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)<0.01
Price to Sales (P/S)1.49
P/FCF Ratio-0.54
Enterprise Value/Market Cap-956.20
Enterprise Value/Revenue-2.44K
Enterprise Value/Gross Profit-11.47K
Enterprise Value/Ebitda778.35
Forecast
1Y Price Target
$3.00Price Target Upside177.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-1.03
Revenue Forecast (FY)$9.00M
Innovative Eyewear, Inc. Business Overview & Revenue Model
Company Description
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphon...
How the Company Makes Money
Innovative Eyewear primarily makes money by selling smart eyewear products (frames that incorporate speakers, microphones, and related electronics) through wholesale and direct-to-consumer channels. Key revenue streams include: (1) product sales o...
Innovative Eyewear, Inc. Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
55
Neutral
Cash Flow
14
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.66M | 1.64M | 1.15M | 659.79K | 690.67K |
| Gross Profit | 567.45K | 215.19K | -119.33K | -56.29K | 148.25K |
| EBITDA | -8.36M | -7.62M | -6.58M | -5.54M | -3.20M |
| Net Income | -7.59M | -7.77M | -6.66M | -5.68M | -3.24M |
Balance Sheet | |||||
| Total Assets | 10.14B | 9.84M | 6.22M | 4.69M | 824.32K |
| Cash, Cash Equivalents and Short-Term Investments | 6.51B | 7.52M | 4.29M | 3.59M | 79.73K |
| Total Debt | 28.49K | 0.00 | 0.00 | 61.36K | 289.03K |
| Total Liabilities | 1.07B | 743.17K | 659.94K | 665.46K | 616.80K |
| Stockholders Equity | 9.07B | 9.10M | 5.56M | 4.02M | 207.52K |
Cash Flow | |||||
| Free Cash Flow | -7.35M | -7.01M | -6.02M | -3.44M | -1.33M |
| Operating Cash Flow | -7.28M | -6.74M | -5.77M | -3.22M | -1.21M |
| Investing Cash Flow | 4.48M | -5.16M | -198.75K | -219.95K | -118.45K |
| Financing Cash Flow | 6.68M | 10.24M | 6.66M | 6.96M | 1.39M |
Innovative Eyewear, Inc. Technical Analysis
Negative
1.08
Price Trends
1.10
Negative
1.26
Negative
1.61
Negative
Market Momentum
>-0.01
Negative
47.13
Neutral
70.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LUCY, the sentiment is Negative. The current price of 1.08 is below the 20-day moving average (MA) of 1.09, below the 50-day MA of 1.10, and below the 200-day MA of 1.61, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.13 is Neutral, neither overbought nor oversold. The STOCH value of 70.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LUCY.
Innovative Eyewear, Inc. Risk Analysis
Innovative Eyewear, Inc. disclosed 43 risk factors in its most recent earnings report. Innovative Eyewear, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Innovative Eyewear, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | $2.56B | -112.73 | 0.45% | ― | 14.55% | ― | |
60 Neutral | $5.84B | -16.79 | -5.61% | ― | 6.23% | 17.53% | |
52 Neutral | $1.31B | -14.54 | -23.24% | ― | -32.42% | -540.37% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | $20.06M | -1.84 | -8.13% | ― | -0.95% | 58.17% | |
42 Neutral | $6.80M | -0.73 | -74.10% | ― | 53.22% | 72.69% |
* Healthcare Sector Average
LUCY
Innovative Eyewear, Inc.
1.08
-1.04
-49.06%
RVP
Retractable Technologies
0.67
-0.03
-4.42%
STAA
Staar Surgical
26.44
9.17
53.10%
WRBY
Warby Parker
20.82
5.96
40.11%
BLCO
Bausch + Lomb Corporation
16.49
4.24
34.61%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.